Model
|
Observations/proposed mechanism
|
Reference
|
Human neuroblastoma SK-N-SH cells |
-
-
Maintenance of mitochondrial membrane potential
-
-
Antioxidant—increase in glutathione, SOD, GSH-Px levels
-
-
Antiapoptotic—downregulation of Bax, caspase-3, 9; upregulation of Bcl-2
|
[58] |
Neuro-2A cells |
|
[59] |
In silico In vitro |
-
-
Inhibition of cholinoesterases—acetylcholinesterase (AChE), butyrylcholinesterase (BChE)
-
-
Inhibition of β-secretase 1 (BACE 1)
|
[60] |
female C57 BL/6 mice |
-
-
Antidepressant-like effect
-
-
Improvement of cognitive performance and spatial memory
-
-
Antioxidant—increase in antioxidant enzymes activity and glutathione levels
|
[61] |
Male Albino Wistar rats |
-
-
Decrease in AChE activity
-
-
Improved learning and memory
-
-
Suppression of APP, β-amyloid, β-, γ-secretases expression
|
[62] |
Male APP/PS1 mice |
|
[63] |
In silico In vitro |
|
[64] |
APPswe/PS1dE9 mice |
-
-
Improvement in learning and memory
-
-
Amelioration of recognition memory
-
-
Antioxidant—an increase of antioxidative defense; decrease in GKS-3β activity
|
[65] |
Adult male C57BL/6 mice |
-
-
Amelioration of motor dysfunction
-
-
Anti-inflammatory—suppression of microglia activation; inhibition of COX-2 and attenuation of inflammatory cytokines—IL-1β, IL-4, IL-6, IL-10, TNF-α release
|
[66] |
Male Wistar rats |
-
-
Anti-apoptotic—a decrease of Bcl-2 and increase of Bax expression
-
-
Amelioration of learning and memory
-
-
Antioxidant—increase in glutathione levels; enhancement of antioxidant enzymes activity—SOD, CAT, GPx
|
[67] |
male transgenic APP/PS1–21 mice |
-
-
Decrease in microglial activation
-
-
Decrease in TGF-1β expression
-
-
Anti-amyloidogenic—attenuation in β-amyloid depositions accumulation and APP expression
|
[68] |
Swiss male albino mice |
-
-
Attenuation of AChE activity
-
-
Anti-inflammatory—inhibition of NF-κB pathway and the release of COX-2 and iNOS
-
-
Inhibition of astrocytes activation
-
-
Improved memory consolidation
|
[69] |
Hesperetin
|
adult male mice (C57BL/6N, wild type) HT22 cells |
-
-
Decrease in oxidative stress (via increase of Nrf2 HO-1 expression)
-
-
Anti-neuroinflammatory effect (reversion of β-amyloid-induced activation of astrocytes and microglia; decrease in TLR4, NF-κB expression)
-
-
Anti-apoptotic (downregulation of proapoptotic markers—Bax, Caspase-3, PARP-1; up-regulation of anti-apoptotic marker—Bcl-2)
-
-
Regulation of synaptic markers—increase in Syntaxin, SNAP-25, PSD-95, Syp, and SNAP-23 levels
-
-
Alleviation of short-term memory dysfunction
|
[70] |
PC12 cells |
|
[71] |
Wistar rats |
-
-
Improvement in learning and recognition memory
-
-
Antioxidant (increase in glutathione and CAT, SOD, GRX, and GPX levels and decrease of lipid peroxidation)
|
[72] |
PC12 cells |
-
-
Decrease in Ca2+ level
-
-
Antioxidantan increase in CAT, GSH-Px, and GRx levels
-
-
Decrease in caspase-3 activity
-
-
Maintenance of mitochondrial membrane potential
-
-
Decrease in DNA damage
|
[73] |
Neuro-2A cells |
|
[59] |
In silico In vitro |
-
-
Inhibition of cholinesterases—acetylcholinesterase (AChE), butyrylcholinesterase (BChE)
-
-
Inhibition of β-secretase 1 (BACE 1)
|
[60] |
ICR female mice |
|
[74] |
Male albino Wistar rats |
-
-
Decrease in AChE activity
-
-
Maintenance of mitochondrial membrane potential
-
-
Antiapoptotic—decrease in Bax, caspase-3, 9 levels and increase in Bcl2
-
-
Antioxidant—increase in CAT, SOD, Gpx, GST activity
|
[75] |
Male C57BL/6 N mice |
-
-
Antioxidant—decreased production of ROS and increased antioxidant proteins Nrf2, HO-1 levels
-
-
Anti-inflammatory—decreased expression of proinflammatory cytokines—TNF-α, IL-1β, p-NF-κB
-
-
Antiapoptotic—decreased expression of p-JNK, Bax, and caspase-3 increased expression of Bcl-2
-
-
Enhanced synaptic integrity, cognition, and memory process
|
[76] |
Male adult Wistar rats PD |
-
-
Improved motor functions
-
-
Attenuation of apoptosis by increased Bcl2 expression
-
-
Attenuation of astrogliosis by a decrease in GFAP levels
-
-
Decreased neuroinflammation by reduction of NF-κB levels
|
[77] |
Cortical cells |
|
[78] |
C57/BL6 male mice BV-2 microglial cells |
-
-
Inhibition of astrocyte and microglial activation
-
-
Anti-inflammatory—attenuation of production of iNOS, NO, IL-6, IL-1β
|
[79] |
SH-SY5Y cells |
-
-
Attenuation of apoptosis—decrease in caspase-3, -9 expression
-
-
Antioxidant—increased levels of GSH, SOD, and expression of NRF2 and HO-1
|
[80] |
Male albino mice |
-
-
Improved spatial learning and reference memory
-
-
Maintenance of cholinergic neurotransmission
-
-
Inhibition of AChE activity
-
-
Antioxidant—increase in SOD and GSH levels
-
-
Increased BDNF levels
|
[81] |
RAW 264.7 Cells |
-
-
Anti-inflammatory effect concerning inhibition of NF-κB and activation of Nrf2/HO-1—suppression of proinflammatory cytokines (TNF-α, IL-6, IL1β) and pro-inflammatory enzymes (iNOS, COX-2) expression
|
[82] |